Molecular structure of BW373U86 dihydrobromide
BW373U86 dihydrobromide
Molecular Weight:
597.43
Molecular Formula:
C27H37N3O2•2HBr
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
BW373U86 dihydrobromide is a potent non-peptide agonist for δ-opioid receptor.
BW373U86 dihydrobromide References
- BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. | Patel, HH., et al. 2001. J Mol Cell Cardiol. 33: 1455-65. PMID: 11448134
- Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice. | Broom, DC., et al. 2002. J Pharmacol Exp Ther. 303: 723-9. PMID: 12388657
- Delta opioid receptor agonist BW373U86 attenuates post-resuscitation brain injury in a rat model of asphyxial cardiac arrest. | Yang, L., et al. 2014. Resuscitation. 85: 299-305. PMID: 24200890
- BW373U86 upregulates autophagy by inhibiting the PI3K/Akt pathway and regulating the mTOR pathway to protect cardiomyocytes from hypoxia-reoxygenation injury. | Liang, Q., et al. 2020. Can J Physiol Pharmacol. 98: 684-690. PMID: 32955950
- BW373U86, a delta-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys. | Butelman, ER., et al. 1995. Eur J Pharmacol. 277: 285-7. PMID: 7493622
- Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. | Negus, SS., et al. 1994. J Pharmacol Exp Ther. 270: 1025-34. PMID: 7932149
- BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells. | Childers, SR., et al. 1993. Mol Pharmacol. 44: 827-34. PMID: 8232233
- Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors. | Comer, SD., et al. 1993. J Pharmacol Exp Ther. 267: 866-74. PMID: 8246161
- A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration. | Dykstra, LA., et al. 1993. J Pharmacol Exp Ther. 267: 875-82. PMID: 8246162
- A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat. | Lee, PH., et al. 1993. J Pharmacol Exp Ther. 267: 883-7. PMID: 8246163
- Alkaloid delta agonist BW373U86 increases hypoxic tolerance. | Bofetiado, DM., et al. 1996. Anesth Analg. 82: 1237-41. PMID: 8638797
- Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors. | Knapp, RJ., et al. 1996. J Pharmacol Exp Ther. 277: 1284-91. PMID: 8667189
- Antagonistic modulation between the delta opioid agonist BW373U86 and the mu opioid agonist fentanyl in mice. | O'Neill, SJ., et al. 1997. J Pharmacol Exp Ther. 282: 271-7. PMID: 9223564
- Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats. | Sezen, SF., et al. 1998. J Pharmacol Exp Ther. 287: 238-45. PMID: 9765343
- Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 2. Place-preference and brain microdialysis studies in rats. | Longoni, R., et al. 1998. Behav Pharmacol. 9: 9-14. PMID: 9832943
Activator of:
DOR.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
BW373U86 dihydrobromide, 10 mg | sc-300314 | 10 mg | $865.00 |